A randomized control trial on the effect of Ciprofloxacin versus Levofloxacin on microbiota diversity in healthy volunteers

Phase 2

• Conditions: Microbiota diversity in healthy volunteer; Levofloxacin, Ciprofloxacin, Microbiota diversity

• Registration Number: TCTR20240712002
• Lead Sponsor: Ratchadapisek Research Funds

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-07-12
• Last Update Posted: 19 August 2024
• Study Completion: 2024-11-14

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Age 18-50 years
No underlying disease
Normal renal and liver function test
Good Digestive health

Exclusion Criteria

Pregnancy
Allergic to FQs
Previous antibiotic use in 2 month
History of bowel resection
Previous use of calcium, ferrous, magnesium supplement and antacids use in 2 month

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Microbiota diversity 5 days after taken medication Shannon index

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A